Developing Strategies to Optimize the Exercise Response After Tetraplegia.

May 11, 2021 updated by: University of Manitoba

Developing Strategies to Optimize the Exercise Response in Persons Living With Tetraplegia.

To identify means to improve exercise performance in participants with tetraplegia.

Study Overview

Detailed Description

Part I. This study will examine the relationship between steady-state and peak exercise performance in participants with tetraplegia or paraplegia.

Participants will have their peak energy expenditure measured using a discontinuous step test. Participants will then perform three different trials of exercise at a steady state at a target intensity that corresponds with 90%, 70%, and 60% of their own measured peak energy expense. Participants will exercise at the prescribed power output until fatigue. Participants may choose which exercise mode they use (with all steady-state trials being in the same mode as the peak test), and may choose to perform the study twice in the different exercise modes. Exercise trials will be performed over a number of different sessions in a randomized order, allowing for adequate rest and recovery between trials, and depending on each participant's capabilities and preferences.

Part II. This study will determine if high intensity interval training (HIIT) results in greater energy expense than constant rate aerobic exercise, and will test if exercising with HITT effects time to fatigue.

Participants will exercise using a high intensity interval training (HIIT) protocol, which involves alternating high intensity bouts of short duration with low intensity bouts of longer duration. Participants will have their peak energy expenditure measured using a discontinuous step test. Participants will then perform one trial of steady-state exercise at a target intensity that corresponds with 50% of their peak energy expense, for a target of 20-45 minutes. Participants will perform a separate trial using a HIIT protocol of exercise at a target intensity that corresponds with 50% of their peak energy expense interspersed with bouts of high intensity (target intensity that corresponds with 90% of peak energy expense) for 30-60 seconds, for a total duration target of 20-45 minutes.

Participants may choose which exercise mode they use (with all trials being in the same mode as the peak test), and may choose to perform the study twice in the different exercise modes. Exercise trials will be performed over a number of different sessions in a randomized order, allowing for adequate rest and recovery between trials, and depending on each participant's capabilities and preferences.

Study Type

Interventional

Enrollment (Anticipated)

16

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 75 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Spinal cord injury of at least one year duration, C5-T12, ASIA impairment scale (AIS) A-D
  • Aged 18-75 years for the duration of the study participation
  • Medically stable and healthy enough to engage in and complete exercise requirements
  • Willing and able to complete the exercise protocols and testing requirements
  • Able to understand and follow written and verbal instructions from study staff
  • Able to communicate with study staff about their exercise capabilities and preferences

Exclusion Criteria:

  • Current serious injury(ies) of the upper extremities
  • Known cardiovascular disease
  • Unsatisfactory results of EKG screening
  • Implanted electronic cardiac device (e.g. pace maker, defibrillator, etc.)
  • Current pressure ulcer(s)
  • Morbid obesity
  • Known thyroid dysfunction
  • Current cancer
  • Current uncontrolled high blood pressure ( > 140/90 mmHg)
  • Uncontrolled epilepsy
  • Current deep vein thrombosis
  • Ventilator-dependent
  • Cognitive impairment

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Basic Science
  • Allocation: Randomized
  • Interventional Model: Crossover Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Interspersing HITT in exercise
We will test whether introducing HITT into an acute exercise bout will increase overall energy expenditure or time to fatigue.
Intermittent bouts of 30-60 seconds of exercise at 90% of peak intensity (HITT).
No Intervention: Acute exercise bout with no HITT
Exercise will occur at 50% peak without introducing HITT.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Energy expenditure in ml of oxygen consumed per minute per kg of body weight
Time Frame: Measured during 20-40 minutes of exercise
Estimation of energy expenditure for bout of exercise
Measured during 20-40 minutes of exercise
Time to fatigue
Time Frame: Measured during 20-40 minutes of exercise
Total duration of exercise
Measured during 20-40 minutes of exercise

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Ratings of perceived exertion
Time Frame: Measured during 20-40 minutes of exercise
Ratings of perceived exertion during exercise
Measured during 20-40 minutes of exercise
Heart rate
Time Frame: Measured during 20-40 minutes of exercise
We will examine differences in average, peak HR and HR variability
Measured during 20-40 minutes of exercise

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Anticipated)

June 1, 2021

Primary Completion (Anticipated)

November 1, 2021

Study Completion (Anticipated)

December 1, 2022

Study Registration Dates

First Submitted

July 7, 2020

First Submitted That Met QC Criteria

July 7, 2020

First Posted (Actual)

July 10, 2020

Study Record Updates

Last Update Posted (Actual)

May 12, 2021

Last Update Submitted That Met QC Criteria

May 11, 2021

Last Verified

June 1, 2020

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Plan Description

Once published we will strive to make anonymized study data available.

IPD Sharing Time Frame

The data will be available once published for one year.

IPD Sharing Supporting Information Type

  • STUDY_PROTOCOL
  • ICF

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Spinal Cord Injuries

Clinical Trials on HITT: intermittent high intensity exercise

3
Subscribe